It is now well-established that due to mutations in Ras or over-expression of receptor tyrosine kinases (RTKs), the Ras pathway becomes hyper-activated in tumor cells, leading to increased cell proliferation and survival [16,17,18]; (2) Down-regulation of the tumor-suppressing protein p53. This evidence concerns the gene TP53 and neoplasm.